Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade in Early Relapsed Prostate Cancer
NCT00103376Phase 2Terminated
- Sponsor
- Medical University of South Carolina
- Start
- Oct 2004
- Primary completion
- Oct 2009
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in prostate cancer (PCa), sponsored by Medical University of South Carolina. Started Oct 2004; status: terminated.
02
Drugs
bortezomib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00103376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103376.